Needham Reiterates Buy on Dentsply Sirona, Maintains $34 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst David Saxon has reiterated a Buy rating on Dentsply Sirona (NASDAQ:XRAY) and maintained a price target of $34.
August 20, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst David Saxon has reiterated a Buy rating on Dentsply Sirona and maintained a price target of $34, indicating confidence in the company's stock performance.
The reiteration of a Buy rating and maintenance of a $34 price target by a reputable analyst suggests a positive outlook for Dentsply Sirona's stock. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100